News

Filter

Current filters:

USAOphthalmicsBelgium

1 to 9 of 96555 results

FDA advisory backs expanded use of Vertex’ CF drug

22-10-2014

There was good news for US biotech firm Vertex Pharmaceuticals yesterday, as a US Food and Drug Administration…

BiotechnologyKalydecoRare diseasesRegulationUSAVertex Pharmaceuticals

Roche to invest billions in new R&D facility and Basel updates

Roche to invest billions in new R&D facility and Basel updates

22-10-2014

Swiss pharma major Roche says it will invest 3 billion Swiss francs ($3.2 billion) in new research infrastructure…

FinancialGeography of EuropePharmaceuticalRocheSwitzerland

Ipsen to commercialize Lexicon carcinoid drug ex-North America/Japan

22-10-2014

French drugmaker Ipsen has entered into an accord with Lexicon Pharmaceuticals to commercialize the US…

EuropeIpsenLexicon PharmaceuticalsLicensingOncologyPharmaceuticaltelotristat etiprate

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

22-10-2014

US-Israeli Immune Pharmaceuticals has funded a study yielding clinical data to demonstrate the importance…

BiotechnologyGastro-intestinalsImmune PharmaceuticalsIsraelResearchUSA

Amgen advised to consider ‘radical’ split by lead investor

Amgen advised to consider ‘radical’ split by lead investor

22-10-2014

One of Amgen’s largest shareholders has said the USA-based biotechnolgy comapny would be better off…

AmgenBiotechnologyFinancialThousand Oaks, CaliforniaUK

PhosImmune and PureMHC to collaborate on antibody-based immunotherapies for cancer

PhosImmune and PureMHC to collaborate on antibody-based immunotherapies for cancer

22-10-2014

Clinical-stage oncology biotech company PhosImmune has entered into a license and collaboration agreement…

BiotechnologyLicensingOncologyPhosImmunePureMHCUSA

Kamada says study supports alpha-1 antitrypsin Glassia for type-1 diabetes

22-10-2014

Israeli biopharma company Kamada says that a comprehensive review of the data available in the literature…

BiotechnologyDiabetesGlassiaKamadaResearch

NICE recommends another new skin cancer drug, GSK’s Tafinlar

22-10-2014

The UK National Institute for Health and Care Excellence (NICE) has issued final guidance recommending…

GlaxoSmithKlineOncologyPharmaceuticalPricingRegulationTafinlarUK

1 to 9 of 96555 results

Back to top